Latest Press Releases - Acquisition / Merger News

Global Veterinary Vaccines Market Is Anticipated Is Witnessing a Steady Growth Rate of 5.75% During the Forecast Period of 2017 to 2022

LogoThe Global Veterinary Vaccines market is poised to reach $9.10 Billion by 2022 from an estimated $6.51 Billion in 2016, at a CAGR of 5.75% from 2015 to 2020.The key factors for increasing the growth of the global veterinary vaccines market are technological innovations, growing awareness about animal health, government bodies and public enterprises are increasing the investments, steady rise in demand for the animal protein such milk, meat, egg, and fish. However, for storage of vaccines pose a major threat to the market owing to high maintenance cost.

"According to Market Data Forecast Recent Report "Global Genetic Testing Market", North America Dominated the Global Market

LogoAccording to a new market research report " Genetic Testing Market by Type (Carrier Testing, Diagnostic Testing, Prenatal Testing and Neonatal Testing), by Application (Cancer Testing, Pharmacogenomics testing, Prenatal testing and Predisposition testing), and by Region – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast (2016– 2022)", published by MarketDataForecast™, the market is expected to reach USD 70.85 Million by 2022 from USD 41.08 Million in 2016, at a CAGR of 9.51%. Increasing geriatric population and rising awareness about the potential benefits of genetic testing are expanding the scope of the genetic testing market. Growing awareness about personalized medicine is also assisting in the growth of maret

NYSE:DPS Shareholder Notice: Investigation of Takeover of Dr Pepper Snapple Group Inc

LogoThe takeover of Dr Pepper Snapple Group Inc is under investigation over possible wrongdoing. The investigation was announced for investors, who currently hold shares of Dr Pepper Snapple Group Inc. (NYSE:DPS).

NYSE:PGEM Investor Alert: Investigation over Possible Wrongdoing in Acquisition of Ply Gem Holdings Inc

LogoAn investigation was announced for investors, who currently hold shares of Ply Gem Holdings Inc (NYSE:PGEM), concerning whether the takeover of Ply Gem Holdings Inc. by Clayton, Dubilier & Rice is unfair.

NYSE:KS Investor Notice: Investigation over Acquisition of KapStone Paper and Packaging Corp

LogoAn investigation was announced on behalf of investors in NYSE:KS shares concerning the takeover of KapStone Paper and Packaging Corp. by WestRock Company.

NASDAQ:CALD Investor Alert: Investigation of Takeover of Callidus Software Inc

LogoAn investigation was announced for investors, who currently hold NASDAQ:CALD shares, concerning whether the takeover of Callidus Software Inc. by SAP SE for $36.00 per share.

NYSE:XRX Investor Alert: Investigation of Takeover of Xerox Corp by FUJIFILM Holdings Corporation

LogoAn investigation was announced for investors, who currently hold shares of Xerox Corp (NYSE:XRX), over the takeover of Xerox Corp. by FUJIFILM Holdings Corporation.

NASDAQ:KTEC Shareholder Alert: Investigation of Takeover of Key Technology, Inc

LogoThe takeover of Key Technology, Inc. is under investigation over possible wrongdoing. The investigation was announced for investors, who currently hold NASDAQ:KTEC shares, concerning whether the takeover of Key Technology, Inc.. by Duravant LLC for $26.75 per share is unfair to NASDAQ:KTEC stockholders.

Calder Associates Announces Another Successful Transaction

Calder Associates, a mergers and acquisitions advisory and business brokerage firm located in Bucks County, PA with offices in Pennsylvania, New Jersey, Maryland and Virginia, have completed another successful transaction. A private investor purchased a construction business. The parties to the transaction asked that the details remain confidential.

NASDAQ:CASC Investor Alert: Investigation of Takeover of Cascadian Therapeutics Inc

LogoThe takeover of Cascadian Therapeutics Inc is under investigation over possible wrongdoing. The investigation was announced for investors, who currently hold NASDAQ:CASC shares, concerning whether the takeover of Cascadian Therapeutics Inc by Seattle Genetics, Inc for $10.00 per share is unfair.